{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:31:40Z","timestamp":1782804700492,"version":"3.54.5"},"reference-count":84,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>For many women, pregnancy and childbirth represent their first major hemostatic challenges. Despite advancements in obstetric care, up to 2 to 5% of all deliveries are complicated by postpartum hemorrhage (PPH). To mitigate bleeding risk, physiological changes occur in pregnancy, including increases in plasma von Willebrand factor (VWF) and factor VIII levels. For women with von Willebrand disease (VWD), these physiological alterations are blunted or absent. As a result, women with VWD have a heightened risk of PPH, both primary (in the first 24\u2009hours) and secondary (&gt;24\u2009hours to 6 to 12 weeks postpartum). Pregnancy and delivery management for women with VWD should therefore be carefully coordinated as part of a multidisciplinary team approach. In the absence of large-scale clinical trials, the management of women with VWD during pregnancy is guided by expert consensus guidelines. Clinical practices internationally are not uniform, and areas of considerable clinical uncertainty exist. Traditional peripartum plasma VWF thresholds for hemostatic cover and therapeutic targets are currently under scrutiny, as PPH is not eliminated in women with VWD who receive replacement therapy. The benefit and optimal duration of postpartum tranexamic acid have yet to be defined, and standardized methods of quantification of blood loss at the time of delivery are currently lacking. In this article, we review the evidence base to date and explore the current clinical challenges in the management of pregnant women with VWD.<\/jats:p>","DOI":"10.1055\/s-0041-1723797","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:31:57Z","timestamp":1614385917000},"page":"217-228","source":"Crossref","is-referenced-by-count":17,"title":["Current Challenges in the Peripartum Management of Women with von Willebrand Disease"],"prefix":"10.1055","volume":"47","author":[{"given":"Bridgette","family":"Byrne","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Coombe Women and Infants University Hospital, Dublin, Ireland"},{"name":"Department of Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Coombe Women and Infants University Hospital, Dublin, Ireland"},{"name":"National Coagulation Centre, St. James' Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lavin","sequence":"additional","affiliation":[{"name":"National Coagulation Centre, St. James' Hospital, Dublin, Ireland"},{"name":"Irish Centre for Vascular Biology, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2516.1999.00302.x","article-title":"Hereditary pseudohaemophilia","volume":"5","author":"E A Von Willebrand","year":"1999","journal-title":"Haemophilia"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/hae.13722","article-title":"Barriers and challenges faced by women with congenital bleeding disorders in Europe: results of a patient survey conducted by the European Haemophilia Consortium","volume":"25","author":"D Noone","year":"2019","journal-title":"Haemophilia"},{"issue":"14","key":"ref3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"M Lavin","year":"2018","journal-title":"Blood Adv"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/hae.13881","article-title":"An international survey to inform priorities for new guidelines on von Willebrand disease","volume":"26","author":"M A Kalot","year":"2020","journal-title":"Haemophilia"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/hae.14043","article-title":"Clinical management of woman with bleeding disorders: a survey among European haemophilia treatment centres","volume":"26","author":"K PM van Galen","year":"2020","journal-title":"Haemophilia"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Y Stirling","year":"1984","journal-title":"Thromb Haemost"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcmd.2016.11.012","article-title":"Developmental hemostasis: a lifespan from neonates and pregnancy to the young and elderly adult in a European white population","volume":"67","author":"U Nowak-G\u00f6ttl","year":"2017","journal-title":"Blood Cells Mol Dis"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"A H James","year":"2015","journal-title":"Haemophilia"},{"key":"ref9","volume-title":"World Population Prospects 2019","author":"United Nations"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2516.2011.02625.x","article-title":"Changes in the levels of factor VIII and von Willebrand factor in the puerperium","volume":"18","author":"F Y Huq","year":"2012","journal-title":"Haemophilia"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2516.1995.tb00056.x","article-title":"Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature","volume":"1","author":"B H Ramsahoye","year":"1995","journal-title":"Haemophilia"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3324\/haematol.2009.011239","article-title":"Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations","volume":"95","author":"G Castaman","year":"2010","journal-title":"Haematologica"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"W L Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000542-200608000-00023","article-title":"Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia\/anesthesia","volume":"105","author":"W Ruppen","year":"2006","journal-title":"Anesthesiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejogrb.2019.05.043","article-title":"Analgesia, anaesthesia and obstetric outcome in women with inherited bleeding disorders","volume":"239","author":"S C Boyd","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1213\/ane.0b013e3181ac13d1","article-title":"Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses","volume":"109","author":"S Choi","year":"2009","journal-title":"Anesth Analg"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"M A Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1111\/1471-0528.14592","article-title":"Management of inherited bleeding disorders in pregnancy: Green-top Guideline No. 71 (joint with UKHCDO)","volume":"124","author":"S Pavord","year":"2017","journal-title":"BJOG"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor","volume":"66","author":"P M Mannucci","year":"1985","journal-title":"Blood"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood.V68.1.58.58","article-title":"Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease","volume":"68","author":"H R Gralnick","year":"1986","journal-title":"Blood"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1172\/JCI69458","article-title":"von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin \u03b1IIb\u03b23","volume":"123","author":"C Casari","year":"2013","journal-title":"J Clin Invest"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","article-title":"The obstetric and gynaecological management of women with inherited bleeding disorders--review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization","volume":"12","author":"C A Lee","year":"2006","journal-title":"Haemophilia"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/hae.13461","article-title":"Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: a national cohort study","volume":"24","author":"E A Chalmers","year":"2018","journal-title":"Haemophilia"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijgo.2013.06.024","article-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","volume":"123","author":"A M Gulmezoglu","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000964","article-title":"How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease","author":"F WG Leebeek","year":"2020","journal-title":"Blood"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/1471-0528.14178","article-title":"Prevention and management of postpartum haemorrhage: Green-top Guideline No. 52","volume":"124","author":"E Mavrides","year":"2017","journal-title":"BJOG"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"L Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"K S Khan","year":"2006","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bmb\/ldg015","article-title":"Global burden of maternal death and disability","volume":"67","author":"C AbouZahr","year":"2003","journal-title":"Br Med Bull"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bpobgyn.2008.08.004","article-title":"Epidemiology of postpartum haemorrhage: a systematic review","volume":"22","author":"G Carroli","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/aogs.12950","article-title":"Increasing incidence of postpartum hemorrhage: the Dutch piece of the puzzle","volume":"95","author":"G van Stralen","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1471-0528.2007.01316.x","article-title":"Investigation of an increase in postpartum haemorrhage in Canada","volume":"114","author":"K S Joseph","year":"2007","journal-title":"BJOG"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2393-9-55","article-title":"Trends in postpartum hemorrhage in high resource countries\u202f: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group","volume":"9","author":"M Knight","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"e0164683","DOI":"10.1371\/journal.pone.0164683","article-title":"Postpartum hemorrhage in women with von Willebrand disease - a retrospective observational study","volume":"11","author":"I Govorov","year":"2016","journal-title":"PLoS One"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH11-03-0180","article-title":"Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease","volume":"106","author":"E M De Wee","year":"2011","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"A H James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/hae.13900","article-title":"von Willebrand Disease and other hereditary haemostatic factor deficiencies in women with a history of postpartum haemorrhage","volume":"26","author":"K Majluf-Cruz","year":"2020","journal-title":"Haemophilia"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrand's disease or factor XI deficiency","volume":"105","author":"R A Kadir","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14696","article-title":"Laboratory monitoring during pregnancy and post\u2010partum hemorrhage in women with Von Willebrand disease","author":"S H O'Brien","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2516.2011.02573.x","article-title":"A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy","volume":"18","author":"D E Trigg","year":"2012","journal-title":"Haemophilia"},{"issue":"07","key":"ref43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00006254-199807000-00025","article-title":"DDAVP use during pregnancy: an analysis of its safety for mother and child","volume":"53","author":"J G Ray","year":"1998","journal-title":"Obstet Gynecol Surv"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"962","DOI":"10.7326\/0003-4819-103-6-962_1","article-title":"Desmopressin and hypotension","volume":"103","author":"E JP Brommer","year":"1985","journal-title":"Ann Intern Med"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.thromres.2006.09.004","article-title":"Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history","volume":"120","author":"A S\u00e1nchez-Luceros","year":"2007","journal-title":"Thromb Res"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1992.tb04598.x","article-title":"Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP)","volume":"82","author":"P M Mannucci","year":"1992","journal-title":"Br J Haematol"},{"issue":"14","key":"ref47","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/bloodadvances.2020002046","article-title":"Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease","volume":"4","author":"N Machin","year":"2020","journal-title":"Blood Adv"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1182\/asheducation-2016.1.683","article-title":"New treatment approaches to von Willebrand disease","volume":"2016","author":"M Lavin","year":"2016","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"05","key":"ref50","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial","volume":"122","author":"P M Mannucci","year":"2013","journal-title":"Blood"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/hematology.2019000065","article-title":"Perioperative management of patients with von Willebrand disease","volume":"2019","author":"J S O'Donnell","year":"2019","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.blre.2019.100633","article-title":"Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: a systematic review","volume":"39","author":"M C Punt","year":"2020","journal-title":"Blood Rev"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/hae.13067","article-title":"Obstetric bleeding among women with inherited bleeding disorders: a retrospective study","volume":"22","author":"L Hawke","year":"2016","journal-title":"Haemophilia"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1700541","article-title":"Type 3 von Willebrand disease in pregnancy: a systematic literature review","author":"M M Makhamreh","year":"2019","journal-title":"Am J Perinatol"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/bloodadvances.2017005090","article-title":"Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease","volume":"1","author":"M V Ragni","year":"2017","journal-title":"Blood Adv"},{"key":"ref57","first-page":"CD007412","article-title":"Active versus expectant management for women in the third stage of labour","volume":"2","author":"C M Begley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijgo.2012.03.001","article-title":"Prevention and treatment of postpartum hemorrhage in low-resource settings","volume":"117","author":"A Lalonde","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/AOG.0000000000002351","article-title":"Practice Bulletin No. 183: Postpartum Hemorrhage","volume":"130","author":"Committee on Practice Bulletins-Obstetrics","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/beog.1999.0060","article-title":"Massive obstetric haemorrhage","volume":"14","author":"J Bonnar","year":"2000","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"03","key":"ref61","doi-asserted-by":"crossref","first-page":"e57594","DOI":"10.1371\/journal.pone.0057594","article-title":"A systematic review of the relationship between blood loss and clinical signs","volume":"8","author":"R C Pacagnella","year":"2013","journal-title":"PLoS One"},{"issue":"08","key":"ref62","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-0528.2006.01018.x","article-title":"Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions","volume":"113","author":"P Bose","year":"2006","journal-title":"BJOG"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0028-2243(91)90188-Q","article-title":"Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery","volume":"38","author":"S J Duthie","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1471-2393-14-276","article-title":"Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss after delivery: a randomized trial","volume":"14","author":"S Ambardekar","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jmwh.2009.02.014","article-title":"Measurement of blood loss: review of the literature","volume":"55","author":"M N Schorn","year":"2010","journal-title":"J Midwifery Womens Health"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"06","key":"ref67","first-page":"CD007872","article-title":"Tranexamic acid for preventing postpartum haemorrhage","author":"N Novikova","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"e5653","DOI":"10.1097\/MD.0000000000005653","article-title":"Is prophylactic tranexamic acid administration effective and safe for postpartum hemorrhage prevention?: a systematic review and meta-analysis","volume":"96","author":"C Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"08","key":"ref69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1800942","article-title":"Tranexamic acid for the prevention of blood loss after vaginal delivery","volume":"379","author":"L Sentilhes","year":"2018","journal-title":"N Engl J Med"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/aogs.12798","article-title":"Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"G Simonazzi","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"ref71","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/jp.2015.93","article-title":"Tranexamic acid and blood loss during and after cesarean section: a meta-analysis","volume":"35","author":"H Y Wang","year":"2015","journal-title":"J Perinatol"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"P A Kouides","year":"2009","journal-title":"Br J Haematol"},{"issue":"03","key":"ref75","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00016347009157244","article-title":"Human placental transfer of an antifibrinolytic agent (AMCA)","volume":"49","author":"S Kullander","year":"1970","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"02","key":"ref76","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/978-3-642-68511-8_39","article-title":"Effects of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding","volume":"5","author":"M Walzman","year":"1982","journal-title":"Arch Toxicol Suppl"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1517\/14656566.2011.545818","article-title":"Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum","volume":"12","author":"P Peitsidis","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"03","key":"ref78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003495-198529030-00003","article-title":"Clinical application of inhibitors of fibrinolysis","volume":"29","author":"M Verstraete","year":"1985","journal-title":"Drugs"},{"issue":"08","key":"ref79","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/bfm.2014.0027","article-title":"Outcome following tranexamic acid exposure during breastfeeding","volume":"9","author":"O Gilad","year":"2014","journal-title":"Breastfeed Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.thromres.2019.05.003","article-title":"Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: a systematic review and meta-analysis","volume":"179","author":"N LJ Chornenki","year":"2019","journal-title":"Thromb Res"},{"issue":"06","key":"ref81","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000438961.38979.19","article-title":"Committee Opinion No.580: von Willebrand disease in women","volume":"122","author":"Committee on Adolescent Health Care","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"07","key":"ref82","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1471-0528.1986.tb07977.x","article-title":"The duration of lochia","volume":"93","author":"L W Oppenheimer","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"56.e1","DOI":"10.1016\/j.ajog.2010.02.042","article-title":"Puerperal loss (lochia) in women with or without inherited bleeding disorders","volume":"203","author":"C Chi","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref84","first-page":"CD002867","article-title":"Treatments for secondary postpartum haemorrhage","author":"J Alexander","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"06","key":"ref85","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1111\/hae.13086","article-title":"A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease","volume":"22","author":"S L Sood","year":"2016","journal-title":"Haemophilia"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1111\/hae.13653","article-title":"A single-centre study of management of pregnant women with von Willebrand disease","volume":"25","author":"Z Xu","year":"2019","journal-title":"Haemophilia"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2516.2009.01984.x","article-title":"Pregnancy and rare bleeding disorders","volume":"15","author":"R Kadir","year":"2009","journal-title":"Haemophilia"},{"issue":"09","key":"ref88","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1991.tb13514.x","article-title":"Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies","volume":"98","author":"I A Greer","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"issue":"04","key":"ref89","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2141.2000.02507.x","article-title":"Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease","volume":"111","author":"M Lak","year":"2000","journal-title":"Br J Haematol"},{"issue":"04","key":"ref90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/hae.12635","article-title":"Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey","volume":"21","author":"S CM Stoof","year":"2015","journal-title":"Haemophilia"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1723797.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T21:24:12Z","timestamp":1698701052000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1723797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":84,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,2,26]]},"published-print":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1723797","relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]}}}